All News

2058 articles, sorted by publication time.

New Drugs and Clinical Trials · global

Retatrutide outperforms Ozempic in blood sugar reduction and weight loss in Phase 3 trial, with higher discontinuation rates

In a head-to-head trial announced by Eli Lilly, retatrutide helped patients with type 2 diabetes lose an average of about one-fifth of their body weight over 80 weeks. The findings add clinical evidence for the triple-receptor drug, but the method used to estimate efficacy, tolerability, and full data yet to be released also affect how the results should be interpreted.

Drug Development · global

Formosa Pharmaceuticals Files European Trial Application for TSY-110, Advancing HER2 Breast Cancer ADC Biosimilar

TSY-110, jointly developed with EirGenix, is planned for comparison with the originator product Kadcyla in safety, pharmacokinetics, and immunogenicity. The application brings development another step closer to testing in humans, but clinical and regulatory hurdles remain before it can potentially offer a more affordable treatment option.